The impact of 30 ml/kg hydroxyethyl starch 130/0.4 vs hydroxyethyl starch 130/0.42 on coagulation in patients undergoing abdominal surgery

Indian Journal of Medical Research

Volumn 136, Issue 3, 2012, Pages 445-450

  Staikou, Chryssoula ^a   Paraskeva, Anteia ^a   Fassoulaki, Argyro ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Abdominal surgery; Coagulation; Colloids; Hydroxyethyl starch; Thombelastography

Indexed keywords

HETASTARCH;

ABDOMINAL SURGERY; ADULT; ARTICLE; BLEEDING TIME; BLOOD CLOTTING; CLINICAL ARTICLE; COLLOID; CONTROLLED STUDY; DRUG DOSE COMPARISON; HUMAN; INTRAOPERATIVE PERIOD; PEROPERATIVE CARE; REACTION TIME; THROMBOELASTOGRAPHY;

ABDOMEN; ADULT; AGED; BLOOD COAGULATION; DOUBLE-BLIND METHOD; HETASTARCH; HUMANS; MIDDLE AGED; PLASMA SUBSTITUTES; THROMBELASTOGRAPHY;

EID: 84867183865     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Lang K, boldt J, Suttner S, Haisch G. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg 2001; 93: 405-9.
2. Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005; 103: 654-60.
3. Boldt J, Suttner S. Plasma substitutes. Minerva Anestesiol 2005; 71: 741-58.
4. Treib J, Haass A, Pindur G. Coagulation disorders caused by hydroxyethylstarch. Thromb Haemost 1997; 78: 974-83.
5. Treib J, baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med 1999; 25: 258-68.
6. Deusch E, Thaler U, Kozek-Langenecker SA. The effects of high molecular weight hydroxyethyl starch solutions on platelets. Anesth Analg 2004; 99: 665-8.
7. Jamnicki M, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR. The effect of potato starch derived and corn starch derived hydroxyethyl starch on in vitro blood coagulation. Anaesthesia 1998; 53: 638-44.
8. Langeron O, Doelberg M, Ang ET, bonnet F, Capdevila X, Coriat P. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 2001; 92: 855-62.
9. Von Roten I, Madjdpour C, Frascarolo P, burmeister MA, Fisch A, Schramm S, et al. Molar substitution and C2/C6 ratioof hydroxyethyl starch: influence on blood coagulation. Br J Anaesth 2006; 96: 455-63.
10. Julier K, Dettori N, Madjdpour C, Frascarolo PH, Spahn DR. Molecular weight does not determine the effect of hydroxyethyl starch on in vitro blood coagulation. Anesthesiology 2004; 101: A273.
11. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008; 106: 1366-75.
12. Lehmann G, Marx G, Forster H. Bioequivalence comparison between hydroxyethyl starch 130/0.42/6: 1 and hydroxyethyl starch 130/0.4/9: 1. Drugs R D 2007; 8: 229-40.
13. Sommermeyer K, Cech F, Schossow R. Differences in chemical structures between waxy maize-and potato starch-based hydroxyethyl starch volume therapeutics. Transfus Altern Transfus Med 2007; l9: 127-33.
14. Gallandat Huet RCG, Siemons AW, baus D, van Rooyen-butijn WT, Haagenaars JAM, Van Oeveren W, et al. A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anesth 2000; 47: 1207-15.
15. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, Kuitunen AH. Gelatin and hydroxyethyl starch but not albumin, impair hemostasis after cardiac surgery. Anesth Analg 2006; 102: 998-1006.
16. Boldt J, Schollhorn T, Munchbach J, Padsdorf M. A total balanced volume replacement strategy using a new balanced hydroxyethyl starch preperation (6% HES 130/0.42) in patients undergoing major abdominal surgery. Eur J Anaesth 2007; 24: 267-75.
17. Waitzinger J, bepperling F, Pabst G, Opitz J. Hydroxyethyl starch (HES) [130/0.4], a new HES specification. Pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers. Drugs R & D 2003; 4: 149-57.
18. Leuschner J, Opitz J, Winkler A, Scharpf R, Bepperling F. Tissue storage of 14C-labelled hydroxyethyl starch (HES) 130/0.4 and HES 200/0.5 after repeated intraveneous administration to rats. Drugs R D 2003; 4: 337-8.
19. Kasper SM, Meinert P, Kampe S, Gorg C, Geisen C, Mehlhorn U, et al. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology 2003; 99: 42-7.
20. Neff TA, Doelberg M, Jungheinrich C, Sauerland A, Spahn DR, Stocker R. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg 2003; 96: 1453-9.
21. Fries D, Innerhofer P, Klingler A, berresheim U, Mittermayr M, Calatzis A, et al. The effect of the combined administration of colloids and lactated Ringer's Solution on the coagulation system:an in vitro study using thrombelastograph coagulation analysis (ROTEG). Anesth Analg 2002; 94: 1280-7.
22. Caprini JA, Zuckerman L, Coher E, Vagher JP, Lipp V. The identification of accelerated coagulability. Thromb Res 1976; 9: 167-80.